American ginseng. III. Pharmacokinetics of ginsenosides in the rabbit

  • S. Edith Chen
  • Ronald J. Sawchuk
  • E. John Staba
Original Papers


The pharmacokinetics of ginsenosides A1, A2, B2, and C were studied in rabbits and were best described with a one-compartment open model. Ginsenoside C (protopanaxadiol group ginseng saponin) showed a significantly longer half-life, higher plasma protein binding, and lower metabolic and renal clearance than ginsenosides A1, A2, and B2 (protopanaxatriol group ginseng saponins). All ginsenosides except ginsenoside A1 were slowly absorbed after intraperitoneal administration. Ginsenosides were not found in rabbit plasma or urine samples after oral administration. The observed differences in the pharmacokinetics of the ginsenosides may be ascribed to differences in protein binding. Ginsenoside C was more toxic than ginsenoside A2 after intraperitoneal administration to mice. Toxicity was not observed after oral administration of any of the ginsenosides. The genins, panaxadiol and panaxatriol, were more toxic and had larger volumes of distribution than the ginsenosides.


Ginseng ginsenosides pharmacokinetics elimination 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Takagi K., Saito H. and Tsuchiya M. (1972): Pharmacological studies ofPanax ginseng root: pharmacological properties of a crude saponin fraction. Jap. J. Pharmacol.,22, 339–346.CrossRefGoogle Scholar
  2. 2.
    Namba T., Yoshizaki M., Tomimori T., Kobashi K., Mitsue K., and Hase J. (1973): Hemolytic and protective activity of ginseng saponins. Chem. Pharm. Bull.,21(2), 459–461.CrossRefGoogle Scholar
  3. 3.
    Kaku T., Miyata T., Urono T., Sako I., and Kinoshita A. (1975): Chemical-pharmacological studies on saponins of Panax ginseng. C.A. Meyer. Arzneim-Forsch.,25(3), 343–347.Google Scholar
  4. 4.
    Chen S.E, and Staba E.J. (1978): American ginseng I. Large scale isolation of ginsenosides from leaves and stems. Lloydia,41(4), 361–366.Google Scholar
  5. 5.
    Shibata S. (1974): Some chemical studies on ginseng. Proc. Inst. Ginseng Symp. (Seoul, Korea), 69–76.Google Scholar
  6. 6.
    Tanaka O. and Yahara S. (1978): Dammarane saponins of leaves ofPanax pseudo-ginseng subsp.himalaicus. Phytochemistry,17, 1353–1358.CrossRefGoogle Scholar
  7. 7.
    Kim J.Y. and Staba E.J. (1974): Plant biochemistry of gin-seng saponins. Proc. Int. Ginseng Symp. (Seoul, Korea), 77–93.Google Scholar
  8. 8.
    Otsuka H., Morita Y., Ogihara Y., and Shibata S. (1977): The evaluation of ginseng and its congeners by droplet counter-current chromatography (DCC). Planta Medica,32, 9–17.CrossRefGoogle Scholar
  9. 9.
    Liberti L.E., and Marderosian, A.D. (1978): Evaluation of commercial ginseng products. J. Pharm. Sci.,67, 1487–1489.CrossRefGoogle Scholar
  10. 10.
    Bombardelli E., Bonati A., Gabetta B., Martineiii E.M. and Mustich G. (1976): Gas-liquid chromatographic and mass spectrometric investigation on saponins inPanax ginseng extracts. Fitoterapia57(3), 99–106.Google Scholar
  11. 11.
    Hartley H.O. (1961): The modified Gauss-Newton method for the fitting of nonlinear regression functions by least squares. Technometrics,3, 269–280.CrossRefGoogle Scholar
  12. 12.
    Hartley H.O. and Booker A. (1965): Nonlinear least squares estimation. Ann. Math. Stat.,36, 638–650.CrossRefGoogle Scholar
  13. 13.
    Okita G.T.: In Digitalis, ed. by Fish C. and Surawicz B., Grune & Stratton (New York 1969), pp 13–14.Google Scholar
  14. 14.
    Doherty J.E. (1973): Digitalis glycosides, pharmacokinetics and their clinical implications. Ann. Intern. Med.,79, 229–238.CrossRefGoogle Scholar
  15. 15.
    Han B.H., Lee E.B., Yoon U.C. and Woo L.K. (1976): Metabolism of dammarane glycosides of Korean ginseng. I. Absorption and excretion of Panax Saponin A. Korean Biochem. J.,9, 21–27.Google Scholar
  16. 16.
    Han B. and Chang I.M. (1977): Metabolism of dammarane triterpene glycosides of Korean ginseng. I. Absorption, organ distribution and excretion of3H-Panax Saponin A. Korean J. Ginseng Sci.,2(1), 17–33.Google Scholar
  17. 17.
    Tagagi K. (1974): Pharmacological studies on ginseng. Proc. Int. Ginseng Symp. (Seoul, Korea), 119–127.Google Scholar
  18. 18.
    Stengel F. and Listabarth H. (1968): Clinical trials of a new geriatric preparation. Ärztliche Praxis,20(4), 130–135.Google Scholar
  19. 19.
    Trabucchi E. (1969): Toxicological and pharmacological examination of “Geriatric” Pharmaton. Forschungsrap-port, Pharmakol. Inst. Milano,31, 1.Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • S. Edith Chen
    • 1
  • Ronald J. Sawchuk
    • 1
  • E. John Staba
    • 1
  1. 1.College of PharmacyUniversity of MinnesotaMinneapolisUSA

Personalised recommendations